OR WAIT null SECS
February 02, 2024
Effective analytics will eliminate failures, deviations, and non-conformances.
Strategizing a PK/PD study approach in early phase development facilitates a successful clinical progression.
Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.
January 04, 2024
Roche will acquire select parts of the LumiraDx group related to that company’s point-of-care technology, which integrates multiple tests on a single instrument.
December 08, 2023
This collaboration will combine BigHat Biosciences’ AI/ML-guided Milliner platform with AbbVie's expertise in oncology and neuroscience to develop next-generation antibodies.
December 06, 2023
Image analysis is crucial for particle analysis of complex finished drug products.
Best practice methods for the tech transfer of CGTs can increase process and analytics robustness while remaining scalable.
November 29, 2023
TAU Systems plans to establish TAU Labs, a new next-generation, laser-driven plasma accelerator laboratory, in Carlsbad, Calif.
Under this multi-year collaboration, Genentech and NVIDIA will use AI to optimize and accelerate each company’s platforms to discover and develop innovative therapeutics.
November 27, 2023
MilliporeSigma has expanded its biosafety testing laboratories in Shanghai, China, with the completion of new lab space at its new €29 million (US$43 million) Biologics Testing Center.